These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 31355470
1. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter. Hussain A, Katz WE, Genuardi MV, Bhonsale A, Jain SK, Kancharla K, Saba S, Shalaby AA, Voigt AH, Wang NC. Pacing Clin Electrophysiol; 2019 Sep; 42(9):1183-1190. PubMed ID: 31355470 [Abstract] [Full Text] [Related]
2. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, van Eickels M, Cohen A, X-TRA study and CLOT-AF registry investigators. Am Heart J; 2016 Aug; 178():126-34. PubMed ID: 27502860 [Abstract] [Full Text] [Related]
4. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Lin C, Quan J, Bao Y, Hua W, Ke M, Zhang N, Jin Q, Xie Y, Wei Y, Ling T, Pan W, Wu L, Xie Y. J Cardiovasc Electrophysiol; 2020 Mar; 31(3):658-663. PubMed ID: 31975470 [Abstract] [Full Text] [Related]
10. Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography. Gunawardene MA, Dickow J, Schaeffer BN, Akbulak RÖ, Lemoine MD, Nührich JM, Jularic M, Sinning C, Eickholt C, Meyer C, Moser JM, Hoffmann BA, Willems S. J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1127-1136. PubMed ID: 28635023 [Abstract] [Full Text] [Related]
11. Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy - Warfarin vs. Direct Oral Anticoagulants. Kawabata M, Goya M, Sasaki T, Maeda S, Shirai Y, Nishimura T, Yoshitake T, Shiohira S, Isobe M, Hirao K. Circ J; 2017 Apr 25; 81(5):645-651. PubMed ID: 28179613 [Abstract] [Full Text] [Related]
12. Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA). Miyazawa K, Pastori D, Hammerstingl C, Cappato R, Meng IL, Kramer F, Cohen A, Schulz A, Eickels MV, Lip GYH, Marin F. Ann Med; 2018 Sep 25; 50(6):511-518. PubMed ID: 29956554 [Abstract] [Full Text] [Related]
13. Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation. Lurie A, Wang J, Hinnegan KJ, McIntyre WF, Belley-Côté EP, Amit G, Healey JS, Connolly SJ, Wong JA. J Am Coll Cardiol; 2021 Jun 15; 77(23):2875-2886. PubMed ID: 34112315 [Abstract] [Full Text] [Related]
18. Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients. Ke HH, He Y, Lv XW, Zhang EH, Wei Z, Li JY. J Thromb Thrombolysis; 2019 Aug 15; 48(2):270-276. PubMed ID: 31165950 [Abstract] [Full Text] [Related]
19. The Safety and Efficacy of Standard-Dose versus Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Left Atrial Appendage Thrombus. Feng M, Lin H, He B, Wang B, Chen X, Chu H. J Healthc Eng; 2021 Aug 15; 2021():1839399. PubMed ID: 34956557 [Abstract] [Full Text] [Related]
20. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic. Lee SI, Sayers M, Lip GY, Lane DA. Int J Clin Pract; 2015 Nov 15; 69(11):1341-8. PubMed ID: 26234557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]